• Je něco špatně v tomto záznamu ?

Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression

J. Václavíková, J. Weber, L. Machala, M. Reiniš, M. Linka, M. Brůčková, J. Vandasová, M. Staňková, J. Konvalinka

. 2005 ; 49 (1) : 29-36.

Jazyk angličtina Země Slovensko

Perzistentní odkaz   https://www.medvik.cz/link/bmc10014992

In this study, 27 HIV-1-positive patients on long-term highly active antiretroviral therapy (HAART) in the Czech Republic were followed for a period of up to 7 years. Variability of the HIV-1 protease (PR) sequence common in the Czech Republic was observed. Under the pressure of inhibitors of protease (PRIs) and reverse transcriptase (RTIs) mutations in PR were detected. Development of resistance to PRIs was followed by a decrease in CD4 count and increase in viral load. The dynamics of viral load closely corresponded to the accumulation of specific primary mutations in PR and RT. Out of 27 patients 18 developed resistance to PRIs and the prolonged therapy led to the accumulation of a higher number of amino acid changes associated with the resistance and, consequently, cross-resistance to several PRIs was observed. These multi-resistant variants of HIV-1 with mutations in PR could not be inhibited sufficiently with PRIs that are currently available in clinical practice. Efficient yet temporary suppression of viral replication was achieved by a lopinavir (LPV) treatment.

000      
03578naa 2200625 a 4500
001      
bmc10014992
003      
CZ-PrNML
005      
20120709184715.0
008      
100623s2005 xo e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xo
100    1_
$a Václavíková, Jana $7 xx0118806
245    10
$a Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression. / $c J. Václavíková, J. Weber, L. Machala, M. Reiniš, M. Linka, M. Brůčková, J. Vandasová, M. Staňková, J. Konvalinka
314    __
$a Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nam 2, 166 10 Prague, Czech Republic
520    9_
$a In this study, 27 HIV-1-positive patients on long-term highly active antiretroviral therapy (HAART) in the Czech Republic were followed for a period of up to 7 years. Variability of the HIV-1 protease (PR) sequence common in the Czech Republic was observed. Under the pressure of inhibitors of protease (PRIs) and reverse transcriptase (RTIs) mutations in PR were detected. Development of resistance to PRIs was followed by a decrease in CD4 count and increase in viral load. The dynamics of viral load closely corresponded to the accumulation of specific primary mutations in PR and RT. Out of 27 patients 18 developed resistance to PRIs and the prolonged therapy led to the accumulation of a higher number of amino acid changes associated with the resistance and, consequently, cross-resistance to several PRIs was observed. These multi-resistant variants of HIV-1 with mutations in PR could not be inhibited sufficiently with PRIs that are currently available in clinical practice. Efficient yet temporary suppression of viral replication was achieved by a lopinavir (LPV) treatment.
650    _2
$a substituce aminokyselin $7 D019943
650    _2
$a látky proti HIV $x aplikace a dávkování $x terapeutické užití $7 D019380
650    _2
$a vysoce aktivní antiretrovirová terapie $7 D023241
650    _2
$a počet CD4 lymfocytů $7 D018791
650    _2
$a progrese nemoci $7 D018450
650    _2
$a virová léková rezistence $x genetika $7 D024882
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genotyp $7 D005838
650    _2
$a HIV infekce $x farmakoterapie $x virologie $7 D015658
650    _2
$a HIV-proteasa $x genetika $7 D016333
650    _2
$a inhibitory HIV-proteasy $x aplikace a dávkování $x terapeutické užití $7 D017320
650    _2
$a HIV reverzní transkriptasa $x genetika $7 D054303
650    _2
$a HIV-1 $x genetika $x izolace a purifikace $x účinky léků $7 D015497
650    _2
$a lidé $7 D006801
650    _2
$a Male
650    _2
$a Mutation
650    _2
$a RNA, Viral $x ge [Genetics]
650    _2
$a Reverse Transcriptase Inhibitors $x ad [Administration & Dosage]
650    _2
$a Reverse Transcriptase Inhibitors $x tu [Therapeutic Use]
650    _2
$a Reverse Transcriptase Polymerase Chain Reaction
650    _2
$a Viral Load
650    _2
$a financování organizované $7 D005381
651    _2
$a Česká republika $7 D018153
700    1_
$a Weber, Jan $7 xx0102542
700    1_
$a Machala, Ladislav, $d 1954- $7 xx0011470
700    1_
$a Reiniš, Milan $7 xx0083033
700    1_
$a Linka, Marek $7 xx0082158
700    1_
$a Brůčková, Marie, $d 1930- $7 jo20010093969
700    1_
$a Vandasová, Jana $7 xx0082159
700    1_
$a Staňková, Marie, $d 1941- $7 jn20000710589
700    1_
$a Konvalinka, Jan, $d 1963- $7 mzk2004208597
773    0_
$t Acta Virologica $w MED00000149 $g Roč. 49, č. 1 (2005), s. 29-36 $x 0001-723X
910    __
$a ABA008 $b A 2823 $y 8
990    __
$a 20100623144517 $b ABA008
991    __
$a 20120709184648 $b ABA008
999    __
$a ok $b bmc $g 750860 $s 614538
BAS    __
$a 3
BMC    __
$a 2005 $b 49 $c 1 $d 29-36 $i 0001-723X $m Acta virologica $n Acta Virol $x MED00000149
LZP    __
$a 2010-B1/mkme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...